Skip to main content
Veterinary Medicines

BioBos IBR marker live, Lyophilisate for suspension

Authorised
  • Infectious Bovine rhinotracheitis virus, strain BIO-27, Live

Product identification

Medicine name:
BioBos IBR marker live, Lyophilisate for suspension
BioBos IBR marker live lyofilizát a rozpúšťadlo na suspenziu
Active substance:
  • Infectious Bovine rhinotracheitis virus, strain BIO-27, Live
Target species:
  • Cattle
Route of administration:
  • Nasal use
  • Intramuscular use

Product details

Active substance and strength:
  • Infectious Bovine rhinotracheitis virus, strain BIO-27, Live
    7.50
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for suspension
Withdrawal period by route of administration:
  • Nasal use
    • Cattle
      • Meat and offal
        0
        day
  • Intramuscular use
    • Cattle
      • Milk
        0
        hour
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AD01
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Package description:
  • Glass Vial 1 x 25.0 Dose
  • Glass Vial 5 x 5.0 Dose

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/024/MR/17-S
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0137/001
Concerned member states:
  • Bulgaria
  • Croatia
  • Cyprus
  • Estonia
  • Greece
  • Hungary
  • Latvia
  • Romania
  • Slovakia
  • Slovenia

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 2/03/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."